Harvard Bioscience Balance Sheet - Quarterly (NASDAQ:HBIO)

Add to My Stocks
$2.95 $0.05 (1.72%) HBIO stock closing price Aug 16, 2017 (Closing)

The Harvard Bioscience balance sheet is a snapshot of the company's financial health at a given point of time, whereas the other two financial statements are for a particular accounting period. Balance sheet items like cash at hand, total assets and liabilities helps one analyze a company and summarize the financial performance of the company like we have in our Harvard Bioscience stock analysis. Good quarterly results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. Whereas, Harvard Bioscience revenue was $25.21M and Harvard Bioscience operating cash flow was $-0.14M for the same period. View Harvard Bioscience quarterly results to get the balance sheet details for the latest & last 40 quarters data..

show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec.2017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
Marketable Securities----------
Raw Materials10.31M9.69M9.79M10.83M11.03M10.69M10.49M11.89M11.2M10.46M
Work In Progress0.76M0.9M0.82M0.93M1.08M1.13M0.88M0.94M1.25M1.35M
Finished Goods9.3M9.68M9.34M9.46M10.09M10.39M10.95M10.16M10.6M10.26M
Notes Receivable----------
Other Current Assets------0.04M2.56M2.6M1.85M
Harvard Bioscience Total Current Assets
Property Plant & Equipment20.06M19.34M18.9M21.98M22.06M22.15M21.92M21.57M21.46M20.55M
Accumulated Depreciation15.78M15.07M14.6M16.71M16.42M16.41M16.01M15.64M15.7M14.97M
Harvard Bioscience Net Property Plant & Equipment
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges1.23M1.17M1.15M0.93M0.95M1.03M0.99M11.04M11.01M10.94M
Deposits & Other Assets0.13M0.14M0.12M0.11M0.09M0.13M0.31M0.34M0.4M0.35M
Harvard Bioscience Total Assets
Notes Payable-------0.01M1.36M2.16M
Accounts Payable5.58M5.83M6.19M6.14M6.57M6.17M8.78M6.32M8.83M7.18M
Current Portion Long-Term Debt2.78M2.72M2.37M2.37M2.38M2.37M2.45M5M5M5M
Current Portion Capital Leases----------
Accrued Expenses3.86M4.42M4.77M4.71M4.19M5.85M4.31M4.05M4.59M4.56M
Income Taxes Payable------2.24M0.24M0.24M0.23M
Other Current Liabilities1.02M1.07M1.26M1.2M1.68M1.49M1.62M1.65M2.55M2.78M
Harvard Bioscience Total Current Liabilities
Deferred Taxes/Income6.56M6.46M6.41M6.53M6.07M6.11M3.77M2.25M2.2M2.17M
Convertible Debt----------
Long-Term Debt10.42M10.93M11.37M12.66M13.77M14.77M16.45M15.15M15.65M16.9M
Non-Current Capital Leases----------
Other Long-Term Liabilities3.43M3.23M3.17M2.64M2.72M2.9M2.98M4.59M4.67M4.78M
Harvard Bioscience Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net0.42M0.41M0.41M0.41M0.41M0.41M0.41M0.41M0.41M0.4M
Capital Surplus216.73M215.84M215.13M214.13M213.1M212.09M211.45M210.65M209.79M207.61M
Retained Earnings-117.55M-117.16M-116.03M-114.71M-113.07M-112.35M-111.72M-94.58M-93.73M-94.08M
Treasury Stock10.67M10.66M10.66M10.66M10.66M10.66M10.66M10.66M10.66M10.66M
Other Liabilities-13.72M-15.7M-16.65M-13.28M-13.11M-11.29M-11.88M-11.53M-10.99M-12.76M
Harvard Bioscience Shareholders Equity
Harvard Bioscience Total Liabilities & Shareholders Equity
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Balance sheet for another ticker

The latest Harvard Bioscience stock price, and Harvard Bioscience historical stock prices show the stock price movement over time, and the Harvard Bioscience PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:
  • Assets: HBIO total assets, which was at $108.86M for 2017-Q2 is a balance sheet item representing value of what Harvard Bioscience owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities: The total liabilities of Harvard Bioscience for 2017-Q2 total to $33.65M. Liabilities for a company like Harvard Bioscience include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.

Harvard Bioscience Balance Sheet - Key Ratios

PB ratio (
price to book ratio